Accesso libero

Successful treatment of epilepsia partialis continua due to Rassmussen encephalitis with perampanel

INFORMAZIONI SU QUESTO ARTICOLO

Cita

Mameniskiene R., Bast T., Bentes C., Canevini M.P., Dimova P., Granata T. et al.:Clinical course and variability of nonRasmussen, nonstroke motor and sensory epilepsia partialis continua: A European survey and analysis of 65 cases. Epilepsia, 2011, 52: 1168–1176.10.1111/j.1528-1167.2010.02974.xSearch in Google Scholar

Rajasekaran K., Joshi S., Kozhemyakin M., Todorovic M.S., Kowalsky S., Balint C., Kapur J.:Receptor trafficking hypothesis revisited: Plasticity of AMPA receptors during established status epilepticus. Epilepsia, 2013, 54 (Suppl. 6): 14–16.10.1111/epi.12266Search in Google Scholar

Redecker J., Wittstock M., Benecke R., Rösche J.:Efficacy of perampanel in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Epilepsy and Behavior, 2015, 45: 176–179.10.1016/j.yebeh.2015.01.036Search in Google Scholar

Rohracher A., Höfler J., Kalss G., Leitinger M., Kuchukhidze G., Deak I. et al.:Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit. Epilepsy and Behavior, 2015, 49: 354–358.10.1016/j.yebeh.2015.04.005Search in Google Scholar

Rösche J., Kampf C., Benecke R.:Possible effect of perampanel on focal status epilepticus after generalized tonic-clonic status epilepticus. Acta Neurologica Belgica, 2014, 114: 243–244.10.1007/s13760-013-0225-3Search in Google Scholar

Rösche J., Redecker J.:Treatment of status epilepticus – A narrative review on the evidence so far and a proposal for the design of retrospective studies. Eur. Med. Journ. Neurol., 2015, 3: 91–95.10.33590/emjneurol/10313357Search in Google Scholar

Shorvon S., Baulac M., Cross H., Trinka E., Walker M.:The drug treatment of status epilepticus in Europe: Consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia, 2008, 49: 1277–1284.10.1111/j.1528-1167.2008.01706_3.xSearch in Google Scholar

Steinhoff B.J.:Das neue Antiepileptikum Perampanel. Psycho-pharmakotherapie, 2012, 19: 202–208.Search in Google Scholar

Trinka E., Hesdorfer D., Rossetti A.O., Scheffer I.E., Shin-nar S. et al.:A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia, 2015a, 56: 1515–1523.10.1111/epi.13121Search in Google Scholar

Trinka E., Steinhoff B.J., Nikanorova M, Brodie M.J.:Peram-panel for focal epilepsy: insights from early clinical experience. Acta Neurol. Scand., 2015b, DOI:10.1111/ane.1252910.1111/ane.12529Search in Google Scholar

Varadkar S., Bien C.G., Kruse C.A., Jensen F.E., Bauer J., Pardo C.A. et al.:Rasmussen’s encephalitis: clinical features, patho-biology and treatment advances. Lancet Neurology, 2014, 13: 195–205.10.1016/S1474-4422(13)70260-6Search in Google Scholar

Watson R., Jiang Y., Bermudez I., Houlihan L., Clover L., McKnight K. et al.:Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology, 2004, 63: 43–50.10.1212/01.WNL.0000132651.66689.0FSearch in Google Scholar

eISSN:
2300-0147
Lingua:
Inglese
Frequenza di pubblicazione:
2 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, other, Neurology, Pharmacology, Toxicology, Pharmacy, Clinical Pharmacy